Clinical Trials
95 trialsLEARN
University of Sydney
ORGAVADS
Centre Francois Baclesse
SHERLOCK
University Health Network, Toronto
Nutritional Status of Head and Neck Cancer Patients
Marmara University
DP-04
AstraZeneca
Biospecimen Procurement for Head and Neck Disorders
National Institutes of Health Clinical Center (CC)
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Oropharynx (OPX) Biomarker Trial
Mayo Clinic
New MRI Biomarkers in Head and Neck Cancers
Memorial Sloan Kettering Cancer Center
EMINENCE
Norwegian University of Science and Technology
Molecular and Genomic Profiling of Head and Neck Tumors
Montefiore Medical Center
EURACAN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
FL-261 Imaging for Cancer Diagnosis and Staging
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Role of the Immune System in Preventing Laryngeal Cancer
European Institute of Oncology
PREtoxEL
European Institute of Oncology
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Memorial Sloan Kettering Cancer Center
MOMENTUM
UMC Utrecht
PEMBRO-PET
University of Rome Tor Vergata
Microbiome in Head and Neck Squamous Cell Carcinoma
University of Colorado, Denver
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
National Taiwan University Hospital
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
RECUT Plus
Royal Marsden NHS Foundation Trust
RESCUE
Royal Marsden NHS Foundation Trust
Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores
Chang Gung Memorial Hospital
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
ELEPHAS-05
Elephas
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Stanford University
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
University of California, San Francisco
PETRiS
XEOS Medical
MIGRAHN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
LIBERATE
University Health Network, Toronto
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
National Institutes of Health Clinical Center (CC)
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Vanderbilt University Medical Center
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
HARMONI
Samsung Medical Center
HOPE
Samsung Medical Center
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
BIOFACE PASS
University Hospital, Toulouse
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
RIX
Second Affiliated Hospital, School of Medicine, Zhejiang University
Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer
Karolinska Institutet
PREMIER
RefleXion Medical
APPOINT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OutcomeH&N
Maastricht Radiation Oncology
HadroQoL
CNAO National Center of Oncological Hadrontherapy
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
Nanfang Hospital, Southern Medical University
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University